Not yet recruiting
Chronic granulomatous disease
Not yet recruitingSafety and efficacy of autologous CD34+ cells transduced with a vector encoding human NCF1 in children and adults with p47‑deficient chronic granulomatous disease
InvestigationalNo placebo
Safety and efficacy of autologous CD34+ cells transduced with a vector encoding human NCF1 in children and adults with p47‑deficient chronic granulomatous disease
InvestigationalNo placebo
- Disease:Chronic granulomatous disease
- Substances:–
Countries:
Germany
Germany- Participants:0–17 years · 18–64 years
- Sponsor:Somagenetix AG

